FDA Inspection 716404 — Smithfield Bioscience Inc
The FDA completed an inspection of Smithfield Bioscience Inc on Mar 28, 2011 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 28, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cincinnati, OH (United States)